2021 Vol.39, N°3 - Table of contents
May-June
One year in review
CER14778
2021,39,3
Pg. 0445-0452
Free to view
One year in review 2021: pathogenesis of rheumatoid arthritis
D. Testa, S. Calvacchi, F. Petrelli, D. Giannini, S. Bilia, A. Alunno, I. Puxeddu
DOI: https://doi.org/10.55563/clinexprheumatol/j1l5l3
D. Testa, S. Calvacchi, F. Petrelli, D. Giannini, S. Bilia, A. Alunno, I. Puxeddu
DOI: https://doi.org/10.55563/clinexprheumatol/j1l5l3
Rapid paper
CER14527
2021,39,3
Pg. 0453-0455
Efficacy and safety of switching Jak inhibitors in rheumatoid arthritis: an observational study
M. Retuerto, E. Trujillo, C. Valero, C. Fernandez-Espartero, C.Y. Soleto, A. Garcia-Valle, E. Aurrecoechea, M. Garijo, A. Lopez, J. Loricera, J.L. Pablos
DOI: https://doi.org/10.55563/clinexprheumatol/cbanza
M. Retuerto, E. Trujillo, C. Valero, C. Fernandez-Espartero, C.Y. Soleto, A. Garcia-Valle, E. Aurrecoechea, M. Garijo, A. Lopez, J. Loricera, J.L. Pablos
DOI: https://doi.org/10.55563/clinexprheumatol/cbanza
Full Papers
CER12772
2021,39,3
Pg. 0456-0462
Free to view
Receptor activator of nuclear factor kappa-Β ligand (RANKL) serum levels are associated with progression to seropositive/negative rheumatoid arthritis
A.N. Burska, J.J. El-Jawhari, J. Wu, R.J. Wakefield, H. Marzo-Ortega, P.G. Conaghan, P. Emery, F. Ponchel, J.E. Freeston
DOI: https://doi.org/10.55563/clinexprheumatol/jj2bxz
A.N. Burska, J.J. El-Jawhari, J. Wu, R.J. Wakefield, H. Marzo-Ortega, P.G. Conaghan, P. Emery, F. Ponchel, J.E. Freeston
DOI: https://doi.org/10.55563/clinexprheumatol/jj2bxz
CER13023
2021,39,3
Pg. 0463-0470
Toenail abnormalities in rheumatoid arthritis patients are associated with radiographic damage and impact disability: a cross sectional study nested within a cohort
G. Sánchez-Cárdenas, I. Contreras-Yáñez, S. Méndez-Flores, J. Merayo-Chalico, A. Barrera-Vargas, J. Domínguez-Cherit, V. Pascual-Ramos
DOI: https://doi.org/10.55563/clinexprheumatol/uav80p
G. Sánchez-Cárdenas, I. Contreras-Yáñez, S. Méndez-Flores, J. Merayo-Chalico, A. Barrera-Vargas, J. Domínguez-Cherit, V. Pascual-Ramos
DOI: https://doi.org/10.55563/clinexprheumatol/uav80p
CER13157
2021,39,3
Pg. 0471-0478
Free to view
Semiquantitative analysis of sacroiliac joint to sacrum ratio of bone scintigraphy to predict spinal progression in early axial spondyloarthritis: a pilot study
H.K. Min, H.-R. Kim, Y. So, H.W. Chung, S.-H. Lee
DOI: https://doi.org/10.55563/clinexprheumatol/jkytz1
H.K. Min, H.-R. Kim, Y. So, H.W. Chung, S.-H. Lee
DOI: https://doi.org/10.55563/clinexprheumatol/jkytz1
CER13256
2021,39,3
Pg. 0479-0486
The effect of methotrexate on neutrophil reactive oxygen species and CD177 expression in rheumatoid arthritis
U. Kaundal, A. Khullar, B. Leishangthem, S. Jain, A. Dhooria, B. Saikia, V. Dhir
DOI: https://doi.org/10.55563/clinexprheumatol/4h5onh
U. Kaundal, A. Khullar, B. Leishangthem, S. Jain, A. Dhooria, B. Saikia, V. Dhir
DOI: https://doi.org/10.55563/clinexprheumatol/4h5onh
CER13126
2021,39,3
Pg. 0487-0493
Absolute reduction of peripheral regulatory T cell in patients with relapsing polychondritis
F.-Y. Hu, J. Wang, S.-X. Zhang, R. Su, N. Yan, C. Gao, X.-F. Li, C.-H. Wang
DOI: https://doi.org/10.55563/clinexprheumatol/qndtvt
F.-Y. Hu, J. Wang, S.-X. Zhang, R. Su, N. Yan, C. Gao, X.-F. Li, C.-H. Wang
DOI: https://doi.org/10.55563/clinexprheumatol/qndtvt
CER13159
2021,39,3
Pg. 0494-0500
Free to view
Phagocytosis and inflammation in crystal-induced arthritis: a synovial fluid and in vitro study
C. Baggio, P. Sfriso, A. Cignarella, P. Galozzi, A. Scanu, F. Mastrotto, M. Favero, R. Ramonda, F. Oliviero
DOI: https://doi.org/10.55563/clinexprheumatol/jcmrd0
C. Baggio, P. Sfriso, A. Cignarella, P. Galozzi, A. Scanu, F. Mastrotto, M. Favero, R. Ramonda, F. Oliviero
DOI: https://doi.org/10.55563/clinexprheumatol/jcmrd0
CER13306
2021,39,3
Pg. 0501-0507
Free to view
Cardiovascular events and change in cholesterol levels in patients with rheumatoid arthritis treated with tocilizumab: data from the REGATE Registry
C. Lukas, M. Redondin, I. Pane, M. Soubrier, E. Houvenagel, J. Sibilia, B. Combe, J. Morel
DOI: https://doi.org/10.55563/clinexprheumatol/hfceu3
C. Lukas, M. Redondin, I. Pane, M. Soubrier, E. Houvenagel, J. Sibilia, B. Combe, J. Morel
DOI: https://doi.org/10.55563/clinexprheumatol/hfceu3
CER13091
2021,39,3
Pg. 0508-0518
Free to view
Novel classification of axial spondyloarthritis to predict radiographic progression using machine learning
Y.B. Joo, I.-W. Baek, K.-S. Park, I. Tagkopoulos, K.-J. Kim
DOI: https://doi.org/10.55563/clinexprheumatol/217pmi
Y.B. Joo, I.-W. Baek, K.-S. Park, I. Tagkopoulos, K.-J. Kim
DOI: https://doi.org/10.55563/clinexprheumatol/217pmi
CER13283
2021,39,3
Pg. 0519-0524
The indirect immunofluorescence assay autoantibody profiles of myositis patients without known myositis-specific autoantibodies
M. Casal-Dominguez, I. Pinal-Fernandez, K. Pak, A. Marin-Sanchez, M.T. Sanz-Martinez, A. Baucells, Y. Hosono, L. Christopher-Stine, A.L. Mammen
for the Johns Hopkins Myositis Center Group
DOI: https://doi.org/10.55563/clinexprheumatol/7kyr5e
M. Casal-Dominguez, I. Pinal-Fernandez, K. Pak, A. Marin-Sanchez, M.T. Sanz-Martinez, A. Baucells, Y. Hosono, L. Christopher-Stine, A.L. Mammen
for the Johns Hopkins Myositis Center Group
DOI: https://doi.org/10.55563/clinexprheumatol/7kyr5e
CER13150
2021,39,3
Pg. 0525-0531
Effectiveness and safety of baricitinib in rheumatoid arthritis: a monocentric, longitudinal, real-life experience
F.R. Spinelli, F. Ceccarelli, C. Garufi, I. Duca, S. Mancuso, E. Cipriano, E. Dell'unto, C. Alessandri, M. Di Franco, C. Perricone, R. Priori, V. Riccieri, R. Scrivo, A. Sili Scavalli, S. Truglia, G. Valesini, F. Conti
DOI: https://doi.org/10.55563/clinexprheumatol/lfg83z
F.R. Spinelli, F. Ceccarelli, C. Garufi, I. Duca, S. Mancuso, E. Cipriano, E. Dell'unto, C. Alessandri, M. Di Franco, C. Perricone, R. Priori, V. Riccieri, R. Scrivo, A. Sili Scavalli, S. Truglia, G. Valesini, F. Conti
DOI: https://doi.org/10.55563/clinexprheumatol/lfg83z
CER13322
2021,39,3
Pg. 0532-0536
Free to view
Disease characteristics of psoriatic arthritis patients may differ according to age at psoriasis onset: cross-sectional data from the Psoriatic Arthritis-International Database
E. Bilgin, S.Z. Aydin, I. Tinazzi, Ö. Bayindir, G. Kimyon, C. Özişler, A. Doğru, E. Dalkiliç, K. Aksu, G. Yildirim Çetin, S. Yilmaz, D. Solmaz, A. Omma, M. Can, O. Küçükşahin, Ş. Yavuz, E.D. Ersözlü, L. Kiliç, E.F. Tarhan, M. Aydin Tufan, L. Akyol, M. Çinar, A. Erden, E. Gönüllü, F. Yildiz, S. Bakirci, F. Erbasan, S. Ergülü Eşmen, A. Küçük, A. Tufan, A. Balkarli, R. Mercan, Ş. Erten, S. Akar, T. Kaşifoğlu, T. Duruöz, V. Yazisiz, U. Kalyoncu
DOI: https://doi.org/10.55563/clinexprheumatol/ert0p7
E. Bilgin, S.Z. Aydin, I. Tinazzi, Ö. Bayindir, G. Kimyon, C. Özişler, A. Doğru, E. Dalkiliç, K. Aksu, G. Yildirim Çetin, S. Yilmaz, D. Solmaz, A. Omma, M. Can, O. Küçükşahin, Ş. Yavuz, E.D. Ersözlü, L. Kiliç, E.F. Tarhan, M. Aydin Tufan, L. Akyol, M. Çinar, A. Erden, E. Gönüllü, F. Yildiz, S. Bakirci, F. Erbasan, S. Ergülü Eşmen, A. Küçük, A. Tufan, A. Balkarli, R. Mercan, Ş. Erten, S. Akar, T. Kaşifoğlu, T. Duruöz, V. Yazisiz, U. Kalyoncu
DOI: https://doi.org/10.55563/clinexprheumatol/ert0p7
CER13251
2021,39,3
Pg. 0537-0545
Real-life persistence of golimumab in patients with chronic inflammatory rheumatic diseases: results of the 2-year observational GO-PRACTICE study
R.-M. Flipo, F. Tubach, P. Goupille, E. Lespessailles, N. Harid, S. Sequeira, P. Bertin, B. Fautrel
DOI: https://doi.org/10.55563/clinexprheumatol/zizo0l
R.-M. Flipo, F. Tubach, P. Goupille, E. Lespessailles, N. Harid, S. Sequeira, P. Bertin, B. Fautrel
DOI: https://doi.org/10.55563/clinexprheumatol/zizo0l
CER13270
2021,39,3
Pg. 0546-0554
Prevalence of hepatitis B virus infection and risk of reactivation in rheumatic population undergoing biological therapy
M.C. Ditto, S. Parisi, V. Varisco, R. Talotta, A. Batticciotto, M. Antivalle, M.C. Gerardi, M. Agosti, R. Borrelli, E. Fusaro, P. Sarzi-Puttini
DOI: https://doi.org/10.55563/clinexprheumatol/c25fja
M.C. Ditto, S. Parisi, V. Varisco, R. Talotta, A. Batticciotto, M. Antivalle, M.C. Gerardi, M. Agosti, R. Borrelli, E. Fusaro, P. Sarzi-Puttini
DOI: https://doi.org/10.55563/clinexprheumatol/c25fja
CER13367
2021,39,3
Pg. 0555-0563
Free to view
Do all antiphospholipid antibodies confer the same risk for major organ involvement in systemic lupus erythematosus patients?
L. Riancho-Zarrabeitia, V.M. Martínez-Taboada, I. Rúa-Figueroa, F. Alonso, M. Galindo-Izquierdo, J. Ovalles, A. Olivé-Marqués, N. Mena Vázquez, J. Calvo-Alén, R. Menor Almagro, E. Tomero Muriel, E. Uriarte Isacelaya, A. Boteanu, M. Andres, M. Freire González, G. Santos Soler, M.E. Ruiz-Lucea, M. Ibáñez-Barceló, I. Castellví, C. Galisteo, V. Quevedo Vila, E. Raya, J. Narváez, L. Expósito, J.A. Hernández Beriaín, L. Horcada, E. Aurrecoechea, J.M. Pego Reigosa
DOI: https://doi.org/10.55563/clinexprheumatol/9kxexc
L. Riancho-Zarrabeitia, V.M. Martínez-Taboada, I. Rúa-Figueroa, F. Alonso, M. Galindo-Izquierdo, J. Ovalles, A. Olivé-Marqués, N. Mena Vázquez, J. Calvo-Alén, R. Menor Almagro, E. Tomero Muriel, E. Uriarte Isacelaya, A. Boteanu, M. Andres, M. Freire González, G. Santos Soler, M.E. Ruiz-Lucea, M. Ibáñez-Barceló, I. Castellví, C. Galisteo, V. Quevedo Vila, E. Raya, J. Narváez, L. Expósito, J.A. Hernández Beriaín, L. Horcada, E. Aurrecoechea, J.M. Pego Reigosa
DOI: https://doi.org/10.55563/clinexprheumatol/9kxexc
CER13405
2021,39,3
Pg. 0564-0569
Seasonal onset of polymyalgia rheumatica: correlations with the pattern of clinical presentation, disease severity and outcome in 383 patients from a single centre
A. Sobrero, S. Paolino, E. Hysa, D. Camellino, V. Tomatis, M. Cutolo, M.A. Cimmino
DOI: https://doi.org/10.55563/clinexprheumatol/vn1qbp
A. Sobrero, S. Paolino, E. Hysa, D. Camellino, V. Tomatis, M. Cutolo, M.A. Cimmino
DOI: https://doi.org/10.55563/clinexprheumatol/vn1qbp
CER12867
2021,39,3
Pg. 0570-0577
Free to view
Mass-spectrometric identification of carbamylated proteins present in the joints of rheumatoid arthritis patients and controls
M.K. Verheul, G.M. Janssen, A. De Ru, G. Stoeken-Rijsbergen, E.N. Levarht, J.C. Kwekkeboom, N. Bomer, A. Ioan-Facsinay, I. Meulenbelt, R.A. Cordfunke, J.W. Drijfhout, R.E. Toes, P.A. Van Veelen, L.A. Trouw
DOI: https://doi.org/10.55563/clinexprheumatol/0ms5pk
M.K. Verheul, G.M. Janssen, A. De Ru, G. Stoeken-Rijsbergen, E.N. Levarht, J.C. Kwekkeboom, N. Bomer, A. Ioan-Facsinay, I. Meulenbelt, R.A. Cordfunke, J.W. Drijfhout, R.E. Toes, P.A. Van Veelen, L.A. Trouw
DOI: https://doi.org/10.55563/clinexprheumatol/0ms5pk
CER13194
2021,39,3
Pg. 0578-0586
Free to view
Atherosclerosis in rheumatoid arthritis: associations between anti-cytomegalovirus IgG antibodies, CD4+CD28null T-cells, CD8+CD28null T-cells and intima-media thickness
B. Wahlin, A.E. Fasth, K. Karp, K. Lejon, V. Malmström, A. Rahbar, S. Wållberg-Jonsson, A. Södergren
DOI: https://doi.org/10.55563/clinexprheumatol/gs3o43
B. Wahlin, A.E. Fasth, K. Karp, K. Lejon, V. Malmström, A. Rahbar, S. Wållberg-Jonsson, A. Södergren
DOI: https://doi.org/10.55563/clinexprheumatol/gs3o43
CER13223
2021,39,3
Pg. 0587-0600
Tissue factor and human apolipoprotein H genetic variants and pro-inflammatory cytokines in systemic lupus erythematosus patients
A. Wajda, A. Sowińska, E. Haładyj, B. Stypińska, J. Nałęcz-Janik, P.P. Jagodziński, D. Majewski, M. Olesińska, A. Paradowska-Gorycka
DOI: https://doi.org/10.55563/clinexprheumatol/5lkj3f
A. Wajda, A. Sowińska, E. Haładyj, B. Stypińska, J. Nałęcz-Janik, P.P. Jagodziński, D. Majewski, M. Olesińska, A. Paradowska-Gorycka
DOI: https://doi.org/10.55563/clinexprheumatol/5lkj3f
CER13275
2021,39,3
Pg. 0601-0605
Prevalence and outcome of thrombocytopenia in systemic lupus erythematous: single-centre cohort analysis
T. Costa Pires, R. Caparrós-Ruiz, P. Gaspar, D.A. Isenberg
DOI: https://doi.org/10.55563/clinexprheumatol/bz64na
T. Costa Pires, R. Caparrós-Ruiz, P. Gaspar, D.A. Isenberg
DOI: https://doi.org/10.55563/clinexprheumatol/bz64na
CER13285
2021,39,3
Pg. 0606-0611
Free to view
Up-regulation of autophagy by etanercept treatment results in TNF-induced apoptosis reduction in EA.hy926 endothelial cell line
C. Barbati, T. Colasanti, M. Vomero, F. Ceccarelli, A.I. Celia, C. Perricone, F.R. Spinelli, F. Conti, G. Valesini, C. Alessandri
DOI: https://doi.org/10.55563/clinexprheumatol/uiqdtq
C. Barbati, T. Colasanti, M. Vomero, F. Ceccarelli, A.I. Celia, C. Perricone, F.R. Spinelli, F. Conti, G. Valesini, C. Alessandri
DOI: https://doi.org/10.55563/clinexprheumatol/uiqdtq
CER13317
2021,39,3
Pg. 0612-0620
Free to view
Immune-related adverse events in patients with solid-organ tumours treated with immunotherapy: a 3-year study of 102 cases from a single centre
I. Gonzalez-Mazón, L. Sánchez-Bilbao, J.L. Martín-Varillas, A. García-Castaño, M. Delgado-Ruiz, I. Bernat Piña, J.L. Hernández, S. Castañeda, J. Llorca, M.A. González-Gay, R. Blanco
DOI: https://doi.org/10.55563/clinexprheumatol/o5nvgv
I. Gonzalez-Mazón, L. Sánchez-Bilbao, J.L. Martín-Varillas, A. García-Castaño, M. Delgado-Ruiz, I. Bernat Piña, J.L. Hernández, S. Castañeda, J. Llorca, M.A. González-Gay, R. Blanco
DOI: https://doi.org/10.55563/clinexprheumatol/o5nvgv
CER13001
2021,39,3
Pg. 0621-0630
Painless and painful synovitis have similar ultrasound and clinical outcomes: one-year cohort study in longstanding rheumatoid arthritis women patients
D.F. Pereira, J. Natour, L.H. Ribeiro, F.B. Ferreira, A.R. Fernandes, R.N. Furtado
DOI: https://doi.org/10.55563/clinexprheumatol/jacpq1
D.F. Pereira, J. Natour, L.H. Ribeiro, F.B. Ferreira, A.R. Fernandes, R.N. Furtado
DOI: https://doi.org/10.55563/clinexprheumatol/jacpq1
CER14295
2021,39,3
Pg. 0631-0638
Free to view
COVID-19 shares clinical features with anti-melanoma differentiation-associated protein 5 positive dermatomyositis and adult Still’s disease
Y. Kondo, Y. Kaneko, H. Takei, H. Tamai, H. Kabata, T. Suhara, R. Yamamoto, H. Nagata, M. Ishii, J. Sasaki, N. Hasegawa, K. Fukunaga, T. Takeuchi
for the Keio Donner Project
DOI: https://doi.org/10.55563/clinexprheumatol/44kaji
Y. Kondo, Y. Kaneko, H. Takei, H. Tamai, H. Kabata, T. Suhara, R. Yamamoto, H. Nagata, M. Ishii, J. Sasaki, N. Hasegawa, K. Fukunaga, T. Takeuchi
for the Keio Donner Project
DOI: https://doi.org/10.55563/clinexprheumatol/44kaji
CER14327
2021,39,3
Pg. 0639-0647
Free to view
Do patients with rheumatoid arthritis show a different course of COVID-19 compared to patients with spondyloarthritis?
R. Hasseli, A. Pfeil, B.F. Hoyer, A. Krause, H.-M. Lorenz, J.G. Richter, T. Schmeiser, R.E. Voll, H. Schulze-Koops, C. Specker, U. Müller-Ladner
DOI: https://doi.org/10.55563/clinexprheumatol/1bq5pl
R. Hasseli, A. Pfeil, B.F. Hoyer, A. Krause, H.-M. Lorenz, J.G. Richter, T. Schmeiser, R.E. Voll, H. Schulze-Koops, C. Specker, U. Müller-Ladner
DOI: https://doi.org/10.55563/clinexprheumatol/1bq5pl
Brief Paper
CER14242
2021,39,3
Pg. 0648-0650
Free to view
Rituximab hypersensitivity reactions and tolerance of ofatumumab therapy
S.B. Ali, C. Yuson, P. Hissaria
DOI: https://doi.org/10.55563/clinexprheumatol/z3mbin
S.B. Ali, C. Yuson, P. Hissaria
DOI: https://doi.org/10.55563/clinexprheumatol/z3mbin
Reviews
CER13440
2021,39,3
Pg. 0651-0659
Epilepsy in systemic lupus erythematosus
E.A. Grasso, M. Cacciatore, C. Gentile, L. Breda, R. Giacomelli, A. Verrotti
DOI: https://doi.org/10.55563/clinexprheumatol/43pqih
E.A. Grasso, M. Cacciatore, C. Gentile, L. Breda, R. Giacomelli, A. Verrotti
DOI: https://doi.org/10.55563/clinexprheumatol/43pqih
CER13499
2021,39,3
Pg. 0660-0667
Incidence of spondyloarthritis subtypes: a systematic review
Y. Alamanos, E. Pelechas, P.V. Voulgari, A.A. Drosos
DOI: https://doi.org/10.55563/clinexprheumatol/yycy0o
Y. Alamanos, E. Pelechas, P.V. Voulgari, A.A. Drosos
DOI: https://doi.org/10.55563/clinexprheumatol/yycy0o
CER13305
2021,39,3
Pg. 0668-0675
Free to view
JAK/STAT pathway and nociceptive cytokine signalling in rheumatoid arthritis and psoriatic arthritis
N. Crispino, F. Ciccia
DOI: https://doi.org/10.55563/clinexprheumatol/e7ayu8
N. Crispino, F. Ciccia
DOI: https://doi.org/10.55563/clinexprheumatol/e7ayu8
CER14406
2021,39,3
Pg. 0676-0687
Free to view
SARS-CoV-2 infection in patients with systemic autoimmune diseases
P. Brito-Zerón, A. Sisó-Almirall, A. Flores-Chavez, S. Retamozo, M. Ramos-Casals
DOI: https://doi.org/10.55563/clinexprheumatol/lekp1y
P. Brito-Zerón, A. Sisó-Almirall, A. Flores-Chavez, S. Retamozo, M. Ramos-Casals
DOI: https://doi.org/10.55563/clinexprheumatol/lekp1y
Paediatric Rheumatology
CER13751
2021,39,3
Pg. 0688-0694
Free to view
Validation of the EULAR/ACR 2017 idiopathic inflammatory myopathy classification criteria in juvenile dermatomyositis patients
E. Sag, S. Demir, Y. Bilginer, B. Talim, G. Haliloglu, S. Ozen
DOI: https://doi.org/10.55563/clinexprheumatol/4tz6ci
E. Sag, S. Demir, Y. Bilginer, B. Talim, G. Haliloglu, S. Ozen
DOI: https://doi.org/10.55563/clinexprheumatol/4tz6ci
Letters to the Editor
CER14147
2021,39,3
Pg. 0695
Free to view
Use of rituximab in a multicentre cohort of patients with rheumatic diseases during the outbreak of novel SARS-COV-2 infection
A. Batticciotto, D. Marotto, V. Giorgi, P. Balzarini, E.G. Favalli, S. Balduzzi, M. Fredi, C. Bazzani, S. Sartorelli, V. Ravagnani, S. Tamanini, L. Castelnovo, A.M. Lurati, S. Farah, S. Bongiovanni, R. Caporali, L. Dagna, P. Faggioli, F. Franceschini, C.M. Montecucco, F. Salaffi, M. Galli, A. Cappelli, P. Sarzi-Puttini
DOI: https://doi.org/10.55563/clinexprheumatol/6z3ong
A. Batticciotto, D. Marotto, V. Giorgi, P. Balzarini, E.G. Favalli, S. Balduzzi, M. Fredi, C. Bazzani, S. Sartorelli, V. Ravagnani, S. Tamanini, L. Castelnovo, A.M. Lurati, S. Farah, S. Bongiovanni, R. Caporali, L. Dagna, P. Faggioli, F. Franceschini, C.M. Montecucco, F. Salaffi, M. Galli, A. Cappelli, P. Sarzi-Puttini
DOI: https://doi.org/10.55563/clinexprheumatol/6z3ong
CER13859
2021,39,3
Pg. 0696
Free to view
Changing the traditional p-value significance threshold to .005 does not decrease the number of statistically significant p-values in observational studies more than in randomised controlled trials
M. Oztas, Z.T. Dincer, N. Sut, H. Yazici
DOI: https://doi.org/10.55563/clinexprheumatol/smg1bu
M. Oztas, Z.T. Dincer, N. Sut, H. Yazici
DOI: https://doi.org/10.55563/clinexprheumatol/smg1bu
CER14312
2021,39,3
Pg. 0697-0699
Free to view
Biological drugs in paediatric COVID-19 infection: what patients, which drug, how much and how long
M.V. Mastrolia, I. Maccora, E. Marrani, I. Pagnini, G. Simonini
DOI: https://doi.org/10.55563/clinexprheumatol/in7kn4
M.V. Mastrolia, I. Maccora, E. Marrani, I. Pagnini, G. Simonini
DOI: https://doi.org/10.55563/clinexprheumatol/in7kn4
CER13907
2021,39,3
Pg. 0700
Free to view
Sustained remission of ankylosing spondylitis following intravesical Bacillus Calmette et Guérin immunotherapy for bladder cancer
E. Toussirot, G. Guichard, P. Saas
DOI: https://doi.org/10.55563/clinexprheumatol/mju681
E. Toussirot, G. Guichard, P. Saas
DOI: https://doi.org/10.55563/clinexprheumatol/mju681
CER14014
2021,39,3
Pg. 0701-0702
Free to view
Novel treatment strategy of polymyalgia rheumatica targeting drug-free remission
T. Hosoya, T. Sugihara, N. Miyasaka, S. Yasuda
DOI: https://doi.org/10.55563/clinexprheumatol/ozxm7y
T. Hosoya, T. Sugihara, N. Miyasaka, S. Yasuda
DOI: https://doi.org/10.55563/clinexprheumatol/ozxm7y
CER11929
2021,39,3
Pg. 0703
Free to view
High prevalence of small intestinal bacterial overgrowth (SIBO) in spondylarthropathy
J.-M. Laroche, N. Kapel, N. Benahmed, P. Claudepierre, X. Chevalier, L. Barbot-Trystram
DOI: https://doi.org/10.55563/clinexprheumatol/nyanfu
J.-M. Laroche, N. Kapel, N. Benahmed, P. Claudepierre, X. Chevalier, L. Barbot-Trystram
DOI: https://doi.org/10.55563/clinexprheumatol/nyanfu
CER13156
2021,39,3
Pg. 0704
Free to view
Resolution of Schnitzler's syndrome after haematopoietic stem cell transplantation
A. Paladini, A. Vitale, B. Frediani, L. Cantarini
DOI: https://doi.org/10.55563/clinexprheumatol/1r3i7i
A. Paladini, A. Vitale, B. Frediani, L. Cantarini
DOI: https://doi.org/10.55563/clinexprheumatol/1r3i7i